Richard Eric Kast (Richard E Kast)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

International journal of molecular sciences

Cells

Brain sciences

Cancers

Roosevelt University (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Roosevelt University

United States

BSC :: Biology

Publications

Richard Eric Kast
IC Regimen: Delaying Resistance to Lorlatinib in ALK Driven Cancers by Adding Repurposed Itraconazole and Cilostazol. Cells 13 (14) (2024)
Richard Eric Kast
IC Regimen: Delaying Resistance to Lorlatinib in ALK Driven Cancers by Adding Repurposed Itraconazole and Cilostazol. Cells 13 (14) (2024)
Richard Eric Kast
The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive. International journal of molecular sciences 24 (20) (2023)
Richard Eric Kast, Alex Alfieri, Hazem I Assi, Terry C Burns, Ashraf M Elyamany, Maria Gonzales Cao, Georg Karpel-Massler, Christine Marosi, Michael E Salacz, Iacopo Sardi, Pieter Van Vlierberghe, Mohamed Saad Zaghloul, Marc-Eric Halatsch
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen. Cancers 14 (10) (2022)
Badar A Kanwar, Asif Khattak, Jenny Balentine, Jong Hoon Lee, Richard Eric Kast
Benefits of Using Dapsone in Patients Hospitalized with COVID-19. Vaccines 10 (2) (2022)
Badar Kanwar, Asif Khattak, Richard Eric Kast
Dapsone Lowers Neutrophil to Lymphocyte Ratio and Mortality in COVID-19 Patients Admitted to the ICU. International journal of molecular sciences 23 (24) (2022)
Richard Eric Kast
High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth-Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen. Cancers 14 (19) (2022)
Jong Hoon Lee, Badar A Kanwar, Asif Khattak, Jenny Balentine, Ngoc Huy Nguyen, Richard Eric Kast, Chul Joong Lee, Jean Bourbeau, Eric L Altschuler, Consolato Maria Sergi, Tuan Ngoc Minh Nguyen, Sangsuk Oh, Mun-Gi Sohn, Michael D Coleman
COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs. International journal of molecular sciences 23 (21) (2022)
Badar Kanwar, Asif Khattak, Richard Eric Kast
Dapsone Lowers Neutrophil to Lymphocyte Ratio and Mortality in COVID-19 Patients Admitted to the ICU. International journal of molecular sciences 23 (24) (2022)
Badar Kanwar, Asif Khattak, Richard Eric Kast
Dapsone Lowers Neutrophil to Lymphocyte Ratio and Mortality in COVID-19 Patients Admitted to the ICU. International journal of molecular sciences 23 (24) (2022)
Richard Eric Kast, Marc-Eric Halatsch, Rafael Rosell
OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs. Cells 10 (5) (2021)
Marc-Eric Halatsch, Annika Dwucet, Carl Julius Schmidt, Julius Mühlnickel, Tim Heiland, Katharina Zeiler, Markus D Siegelin, Richard Eric Kast, Georg Karpel-Massler
In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Richard Eric Kast
Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation. Medical sciences (Basel, Switzerland) 9 (1) (2021)
Richard Eric Kast, Alex P Michael, Iacopo Sardi, Terry C Burns, Tim Heiland, Georg Karpel-Massler, Francois G Kamar, Marc-Eric Halatsch
A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen. Brain sciences 10 (1) (2020)
Richard Eric Kast, Nicolas Skuli, Iacopo Sardi, Felix Capanni, Martin Heßling, Guido Frosina, Anton P Kast, Georg Karpel-Massler, Marc-Eric Halatsch
Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen. Brain sciences 8 (12) (2018)
Richard Eric Kast
Paths for Improving Bevacizumab Available in 2018: The ADZT Regimen for Better Glioblastoma Treatment. Medical sciences (Basel, Switzerland) 6 (4) (2018)

Richard Eric Kast.css-eqlu8i{font-size:small;padding-left:4px;} (Richard E Kast)

Publication Activity (10 Years)

Top Topics

Top Venues

Richard Eric Kast (Richard E Kast)